| scholarly article | Q13442814 |
| P50 | author | Dominique Decre | Q67472916 |
| P2093 | author name string | Frédéric Barbut | |
| Jean-Claude Petit | |||
| Béatrice Burghoffer | |||
| Carina Gonçalves | |||
| P2860 | cites work | Comparison of serogrouping and polyacrylamide gel electrophoresis for typing Clostridium difficile. | Q40207625 |
| Restriction endonuclease DNA analysis of Clostridium difficile | Q40209818 | ||
| Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions. | Q40224029 | ||
| Clostridium difficile colitis | Q40679117 | ||
| Nosocomial acquisition of Clostridium difficile infection | Q41877583 | ||
| Use of the Polymerase Chain Reaction for the Specific and Direct Detection of Clostridium dijficile in Human Feces | Q46408709 | ||
| Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing | Q47952103 | ||
| Diarrhoea associated with toxigenic Clostridium spiroforme | Q63762155 | ||
| Nosocomial infection with Clostridium difficile investigated by pyrolysis mass spectrometry | Q67580912 | ||
| Clostridium difficile--a spectrum of virulence and analysis of putative virulence determinants in the hamster model of antibiotic-associated colitis | Q69149136 | ||
| Clostridium spiroforme toxin is a binary toxin which ADP-ribosylates cellular actin | Q69919075 | ||
| Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile | Q70477362 | ||
| Isolation of Clostridium difficile at a university hospital: a two-year study | Q71716779 | ||
| Ten Years of Prospective Clostridium difficile-Associated Disease Surveillance and Treatment at the Minneapolis VA Medical Center, 1982–1991 | Q71950506 | ||
| Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile | Q73184788 | ||
| Binary toxin producing Clostridium difficile strains | Q80057465 | ||
| Toxigenic clostridia | Q24616838 | ||
| Characterization of Clostridium perfringens iota-toxin genes and expression in Escherichia coli | Q24655877 | ||
| Comparison of toxinotyping and PCR ribotyping of Clostridium difficile strains and description of novel toxinotypes | Q30649866 | ||
| New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia | Q31134424 | ||
| Clostridium perfringens: toxinotype and genotype | Q33594366 | ||
| Analysis of the pathogenicity locus in Clostridium difficile strains | Q33889508 | ||
| Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile | Q33901190 | ||
| Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. | Q33967582 | ||
| Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates | Q34146714 | ||
| The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins | Q34312684 | ||
| Glucosylation of Rho proteins by Clostridium difficile toxin B. | Q34312765 | ||
| Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism | Q34333946 | ||
| How to detect Clostridium difficile variant strains in a routine laboratory | Q34395287 | ||
| Definition of the single integration site of the pathogenicity locus in Clostridium difficile. | Q34411605 | ||
| Clinical practice. Antibiotic-associated diarrhea | Q34512995 | ||
| Purification of the Clostridium spiroforme binary toxin and activity of the toxin on HEp-2 cells | Q35100507 | ||
| Mechanisms of the cytopathic action of actin-ADP-ribosylating toxins | Q35655245 | ||
| Nucleotide sequence of Clostridium difficile toxin B gene | Q35849070 | ||
| Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain | Q36998815 | ||
| Identification of toxigenic Clostridium difficile by the polymerase chain reaction. | Q37228924 | ||
| Cellular and molecular actions of binary toxins possessing ADP-ribosyltransferase activity | Q37505427 | ||
| A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins | Q38326211 | ||
| Characterization of the enzymatic component of the ADP-ribosyltransferase toxin CDTa from Clostridium difficile | Q39522253 | ||
| A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. | Q39554772 | ||
| Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France | Q39664770 | ||
| Production of a complete binary toxin (actin-specific ADP-ribosyltransferase) by Clostridium difficile CD196. | Q39829481 | ||
| Frequency of Binary Toxin Genes among Clostridium difficile Strains That Do Not Produce Large Clostridial Toxins | Q40173019 | ||
| Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea | Q40178406 | ||
| Use of an enzyme-linked immunoassay for Clostridium difficile serogrouping | Q40188945 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Clostridium difficile | Q310543 |
| P304 | page(s) | 1933-1939 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
| P1476 | title | Prevalence and characterization of a binary toxin (actin-specific ADP-ribosyltransferase) from Clostridium difficile | |
| P478 | volume | 42 |
| Q89717493 | A Drosophila Model for Clostridium difficile Toxin CDT Reveals Interactions with Multiple Effector Pathways |
| Q45228181 | A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes |
| Q39158452 | A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile. |
| Q36094307 | Bacterial cytotoxins: targeting eukaryotic switches |
| Q36607411 | Bacterial enteric infections in children: etiology, clinical manifestations and antimicrobial therapy |
| Q36314296 | Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator |
| Q36077222 | CdtR Regulates TcdA and TcdB Production in Clostridium difficile |
| Q36996846 | Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region |
| Q36898358 | Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006 |
| Q41915248 | Chloroquine derivatives block the translocation pores and inhibit cellular entry of Clostridium botulinum C2 toxin and Bacillus anthracis lethal toxin |
| Q50554093 | Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients. |
| Q40458839 | Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. |
| Q40770963 | Clonal spread of a Clostridium difficile strain with a complete set of toxin A, toxin B, and binary toxin genes among Polish patients with Clostridium difficile-associated diarrhea |
| Q33728296 | Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance |
| Q60500782 | Clostridium difficile infection |
| Q26864237 | Clostridium difficile infection: molecular pathogenesis and novel therapeutics |
| Q33243642 | Clostridium difficile ribotype 027, toxinotype III, the Netherlands |
| Q27316166 | Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria |
| Q61821090 | Clostridium difficile: Investigating Transmission Patterns Between Infected and Colonized Patients Using Whole Genome Sequencing |
| Q39485497 | Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium |
| Q42909805 | Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins |
| Q42939937 | Detection of toxins A/B and isolation of Clostridium difficile and Clostridium perfringens from dogs in Minas Gerais, Brazil |
| Q36261170 | Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains |
| Q26777157 | Diagnostic accuracy of loop-mediated isothermal amplification in detection of Clostridium difficile in stool samples: a meta-analysis |
| Q40740746 | EGA Protects Mammalian Cells from Clostridium difficile CDT, Clostridium perfringens Iota Toxin and Clostridium botulinum C2 Toxin |
| Q46353482 | Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. |
| Q42220493 | Emergence of a ribotype 244 strain of Clostridium difficile associated with severe disease and related to the epidemic ribotype 027 strain |
| Q93016993 | Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With Clostridioides difficile Infection |
| Q49405828 | Epidemiological Features of Clostridium difficile Colonizing the Intestine of Jordanian Infants. |
| Q38068605 | Epidemiology, diagnosis and treatment of Clostridium difficile infection |
| Q99635869 | Evaluation of inpatients Clostridium difficile prevalence and risk factors in Cameroon |
| Q47147465 | Frequency of antibiotic associated diarrhea caused by Clostridium difficile among hospitalized patients in intensive care unit, Kerman, Iran |
| Q37145737 | Genotypic investigation of Clostridium difficile in Prince Edward Island |
| Q38350907 | Immune-based treatment and prevention of Clostridium difficile infection |
| Q36497942 | Increasing prevalence of toxin A-negative, toxin B-positive isolates of Clostridium difficile in Korea: impact on laboratory diagnosis |
| Q39878458 | Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model |
| Q58376505 | Isolation and Characterization of a New Clostridium difficile Ribotype During a Prospective Study in a Hospital in Italy |
| Q57212905 | Isolation and characterization of Clostridium difficile associated with beef cattle and commercially produced ground beef |
| Q44863086 | Longitudinal study comparing the dynamics of Clostridium difficile in conventional and antimicrobial free pigs at farm and slaughter |
| Q38629563 | Membrane translocation of binary actin-ADP-ribosylating toxins from Clostridium difficile and Clostridium perfringens is facilitated by cyclophilin A and Hsp90. |
| Q35861348 | Metagenomic Approach for Identification of the Pathogens Associated with Diarrhea in Stool Specimens |
| Q34719551 | Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada |
| Q80657875 | Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period |
| Q79368408 | Molecular analysis of Clostridium difficile isolates recovered from horses with diarrhea |
| Q38036703 | Molecular basis of early stages of Clostridium difficile infection: germination and colonization |
| Q39422769 | Multiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples. |
| Q34605658 | New trends in Clostridium difficile virulence and pathogenesis |
| Q38995111 | Prevalence and Characterization of Clostridium difficile in Beef and Mutton Meats of Isfahan Region, Iran. |
| Q64334644 | Prevalence of binary-toxin genes ( and ) among clinical strains of isolated from diarrheal patients in Iran |
| Q37261892 | Recent developments on the role of Clostridium difficile in inflammatory bowel disease |
| Q43526305 | Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease |
| Q40788336 | Role of binary toxin in the outcome of Clostridium difficile infection in a non-027 ribotype setting |
| Q42753163 | Tailored cyclodextrin pore blocker protects mammalian cells from clostridium difficile binary toxin CDT. |
| Q36467690 | The comparative pathology of Clostridium difficile-associated disease |
| Q38036704 | The continually evolving Clostridium difficile species |
| Q36889259 | The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge |
| Q37954308 | The enterotoxicity of Clostridium difficile toxins |
| Q34006236 | The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives. |
| Q38899041 | Tolevamer, an anionic polymer, neutralizes toxins produced by the BI/027 strains of Clostridium difficile |
| Q93165967 | Toxin A and B genes expression of Clostridium difficile in the sub-minimum inhibitory concentration of clindamycin, vancomycin and in combination with ceftazidime |
| Q58924160 | Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe |
| Q94562683 | Toxin profiles and antimicrobial resistance patterns among toxigenic clinical isolates of Clostridioides (Clostridium) difficile |
| Q33475206 | Truncation in the tcdC region of the Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A |
| Q37050248 | Update on the changing epidemiology of Clostridium difficile-associated disease |
| Q38196682 | Vaccines against Clostridium difficile |
| Q28475218 | Variations in TcdB Activity and the Hypervirulence of Emerging Strains of Clostridium difficile |
Search more.